Ohio SB 56 Hemp Law: What Cannabis and Hemp Businesses Need to Know in 2026

Date April 8, 2026
Categories
Article Authors

Update September 2026.

Ohio’s hemp and cannabis regulatory landscape continues to evolve following the March 20, 2026 effective date of Senate Bill 56.

Since this article was originally published, two significant developments have occurred:

Ohio SB 56 Faces Ongoing Federal Court Challenges

Portions of Ohio’s SB 56 framework are being challenged in federal court. Certain hemp businesses have obtained preliminary relief preventing enforcement of portions of the law against the businesses involved in those cases.

An August 7, 2026 federal court ruling blocked enforcement against businesses involved in one challenge. However, businesses should not assume that court relief granted to specific plaintiffs automatically applies to every hemp or cannabis business operating in Ohio.

Companies should continue monitoring the litigation and consult qualified legal counsel regarding how current court decisions may affect their products and operations.

Federal Hemp Restrictions Mostly Delayed Until December 11, 2026

The federal hemp rules originally scheduled to take effect November 12, 2026 have also changed.

On September 2, 2026, President Donald Trump signed H.R. 6500, the Continuing Appropriations and Extensions Act, 2027, into law. The legislation effectively delays most of the upcoming federal hemp restrictions until December 11, 2026.

Certain provisions involving cannabinoids that cannot naturally be produced by a Cannabis sativa L. plant remain scheduled to apply beginning November 12, 2026.

For businesses, this creates two important federal dates:

  • November 12, 2026: Certain restrictions involving cannabinoids that cannot naturally be produced by the cannabis plant are scheduled to take effect.
  • December 11, 2026: Most remaining federal hemp restrictions, including the new total-THC standard and 0.4-milligram combined-total-per-container standard for certain finished products, are scheduled to apply.
  • The additional time gives hemp and cannabis businesses another opportunity to review product formulations, testing, inventory, suppliers and financial exposure, but it does not eliminate the upcoming federal changes.

The Regulatory Shift

Senate Bill 56, signed by Governor Mike DeWine on December 19, 2025, reclassifies any product containing more than 0.4 milligrams of total THC per container as marijuana1. This means intoxicating hemp products—including delta-8 gummies, THCA flower, and THC-infused beverages—can no longer be sold at gas stations, smoke shops, convenience stores, or other unlicensed retail locations. These products are now restricted exclusively to Ohio’s licensed cannabis dispensaries, which are regulated by the Division of Cannabis Control2.

The law represents Ohio’s response to what state lawmakers and regulators identified as a regulatory gap: the proliferation of untested, unregulated intoxicating hemp products in retail environments where age verification and product safety oversight were inconsistent3.

Federal Context and Implementation Timeline

Ohio’s ban occurred against the backdrop of federal regulatory changes. In November 2025, Congress passed legislation limiting legal hemp products to 0.4 milligrams of total THC per container, with a one-year implementation delay extending to November 20264. This created a compressed timeline for Ohio: while the federal government allowed states a full year to adapt, Ohio moved more quickly, giving businesses just over three months from the law’s signing to full enforcement on March 20, 2026.

This shorter implementation window meant rapid operational changes for affected businesses. Retailers carrying intoxicating hemp products faced decisions about returning inventory, halting orders, and communicating the regulatory shift to customers accustomed to purchasing these items at convenience locations5.

What Changed on March 20, 2026

The practical impact of Senate Bill 56 includes:

Product Reclassification: Any product exceeding 0.4 mg total THC per container is now legally classified as marijuana, regardless of whether it was previously marketed as hemp-derived.

Retail Restriction: Intoxicating hemp products can only be sold through Ohio’s licensed cannabis dispensaries. The state has capped total dispensary licenses at 400 locations6.

Geographic Requirements: Dispensaries must maintain specified distances from schools, playgrounds, and churches, which may affect where new licensed locations can open7.

Enforcement: Selling intoxicating hemp products outside licensed dispensaries now constitutes a first-degree misdemeanor on first offense and a fifth-degree felony on subsequent offenses8.

Age Verification: Licensed dispensaries enforce age 21+ requirements for all purchases, eliminating the previous scenario where these products were accessible to minors in unlicensed retail settings9.

Implications for Cannabis Business Owners

For dispensary operators, Senate Bill 56 represents a market consolidation opportunity. Products that were previously sold in thousands of unlicensed retail locations across Ohio are now channeled through the state’s regulated dispensary system. This shift may increase foot traffic and revenue opportunities for licensed operators.

For businesses previously selling intoxicating hemp products outside the licensed system, the law requires an immediate operational pivot. Some may pursue cannabis retail licensing if eligible and if licenses remain available under the 400-location cap. Others may focus on non-intoxicating hemp products that remain compliant with the 0.4 mg threshold, though this represents a significant narrowing of product offerings.

Manufacturers and distributors must also recalibrate. Products formulated to comply with previous federal hemp definitions (less than 0.3% delta-9 THC by dry weight) may no longer be viable in Ohio if total THC per container exceeds 0.4 mg. Product reformulation or market exit become the available options.

Compliance Considerations

Cannabis business owners should verify:

Product Testing: All products sold through dispensaries must meet Division of Cannabis Control testing and safety standards, which differ from the largely unregulated environment in which many hemp products previously operated.

Inventory Management: Licensed dispensaries should confirm that any newly added hemp-derived products comply with both the 0.4 mg threshold and all other state cannabis regulations.

Documentation: Maintain clear records demonstrating compliance with licensing requirements, product testing protocols, and age verification procedures.

Interstate Commerce: Ohio law prohibits bringing marijuana into the state from other states, even if purchased legally elsewhere, as federal law still classifies marijuana as an illegal substance10.

Business and Financial Considerations Beyond Compliance

Changes to hemp and cannabis regulation can have consequences beyond whether a particular product can legally be sold.

Cannabis and hemp businesses should consider how SB 56 and the upcoming federal changes could affect:

Inventory: Products that no longer meet applicable requirements could create slow-moving or unsellable inventory and potential write-down considerations.

Product mix: Retailers and manufacturers may need to evaluate which product categories remain financially viable under new state and federal rules.

Vendor relationships: Companies should review supplier representations, testing documentation and contractual responsibilities if a product’s regulatory status changes.

Cash flow: Lost sales, reformulation expenses, additional testing or changes to distribution can create short-term working-capital pressure.

Forecasting: Businesses may need to revise revenue and margin assumptions as the regulated cannabis and hemp-derived product markets evolve.

Multistate operations: Companies operating across jurisdictions may need different inventory, product and compliance strategies for individual states.

A coordinated review involving legal, accounting, tax and operational advisers can help businesses understand the broader impact of regulatory changes.

Regulatory changes can affect far more than compliance. Inventory value, cash flow, supplier agreements and financial forecasts may all need to change with them.

Federal Hemp Restrictions Delayed Until December 11, 2026

The federal hemp regulatory timeline has changed since this article was originally published.

Federal legislation enacted in November 2025 established new restrictions affecting certain hemp-derived cannabinoid products that were originally scheduled to take effect November 12, 2026.

On September 2, 2026, President Trump signed H.R. 6500, the Continuing Appropriations and Extensions Act, 2027, into law. The legislation effectively delays most of those upcoming federal hemp restrictions until December 11, 2026.

Certain provisions involving cannabinoids that cannot naturally be produced by a Cannabis sativa L. plant remain scheduled to take effect November 12.

For hemp and cannabis businesses, the distinction is important. Companies should evaluate individual products rather than treating either date as a universal deadline.

Businesses should continue reviewing product formulations, cannabinoid content, testing procedures, sourcing and inventory while monitoring whether Congress takes additional action before December 11.

Frequently Asked Questions

Non-intoxicating hemp products that stay within Ohio’s 0.4 mg total THC per container threshold remain generally permissible under current law and do not require dispensary-exclusive sale. However, businesses should verify product testing and labeling comply with all applicable regulations.

Products exceeding the 0.4 mg threshold became illegal to sell outside licensed dispensaries on March 20, 2026. Unlicensed retailers cannot legally sell remaining inventory and should consult legal counsel about proper disposition options.

CBD products containing 0.4 mg or less total THC per container remain legal for sale outside dispensaries. Products exceeding this threshold are now classified as marijuana and restricted to licensed dispensary sales.

The statewide cap limits total licensed dispensary locations to 400. The Division of Cannabis Control manages license allocation through Ohio’s cannabis regulatory system. Prospective applicants should confirm license availability and application procedures directly with the Division.

The law includes specific provisions for liquor license holders regarding certain drinkable cannabinoid products, though Governor DeWine vetoed portions of the bill that would have extended these exceptions through the end of 2026. Licensed cannabis dispensaries remain the primary authorized retail channel for intoxicating hemp products.

No. SB 56 did not ban all hemp. It narrowed the products that qualify as hemp under Ohio law and changed how products falling outside that definition are regulated.

Ohio law excludes certain final hemp-derived cannabinoid products from the definition of hemp when they contain greater than 0.4 milligrams combined total per container of specified cannabinoids, including total THC and THCA. The statutory definition includes additional requirements, so businesses should not treat 0.4 milligrams as the law’s only product standard.

Whether a particular delta-8 product qualifies as hemp depends on the product’s cannabinoid composition, how the cannabinoid was produced and other requirements in Ohio law. Businesses should evaluate individual products rather than relying solely on the product’s marketing name.

The answer depends on the product and how it is classified under current Ohio law. SB 56 significantly changed the treatment of hemp-derived cannabinoid products, including beverages, and portions of the regulatory framework remain subject to litigation. Businesses should obtain current legal guidance before selling or distributing affected beverages.

Not every CBD product is necessarily excluded from Ohio’s definition of hemp. Businesses should review finished products for THC, THCA, other relevant cannabinoids and manufacturing methods to determine whether they satisfy current statutory requirements.

Most of the federal hemp restrictions previously scheduled to take effect November 12, 2026, are now effectively delayed until December 11, 2026. Certain provisions involving cannabinoids that cannot naturally be produced by a Cannabis sativa L. plant remain tied to November 12.


Footnotes:

1Ohio Capital Journal, “New Ohio law banning intoxicating hemp products, THC and CBD beverages takes effect,” March 20, 2026.

2Spectrum News 1, “Ohio’s marijuana and hemp rules take effect,” March 20, 2026.

3ABC6 On Your Side, “What to Know: Ohio’s hemp ban takes effect, clearing shelves for non-licensed retailers,” March 22, 2026.

4Ohio Capital Journal, “New Ohio law banning intoxicating hemp products, THC and CBD beverages takes effect,” March 20, 2026.

513 ABC, “New Ohio law means THC-infused drinks won’t be available on many store shelves,” March 6, 2026.

6News Talk Cleveland, “Ohio Cannabis Law Update 2026: 10 Major Changes You Should Know,” March 19, 2026.

7Spectrum News 1, “Ohio’s marijuana and hemp rules take effect,” March 20, 2026.

8Cannabis Business Times, “Ohio Senate Passes Bill to Limit Hemp Product Sales to Licensed Dispensaries, Liquor Stores,” 2025.

9Spectrum News 1, “Intoxicating hemp ban in effect in Ohio — what you won’t see on shelves anymore,” March 24, 2026.

10News Talk Cleveland, “Ohio Cannabis Law Update 2026: 10 Major Changes You Should Know,” March 19, 2026.

Speak to one of our professionals about your organizational needs

"*" indicates required fields